TNF and Crohn disease: Indeed, TNF inhibitors carry warnings for increased risk of hematological malignancies in children, adolescents, and young adults, primarily treated for ulcerative colitis or Crohn's disease also treated with immunosuppressant (azathioprine and/or mercaptopurine).